IRIS Bag

2D bioprocess container

IRIS 2D single-use bags for safe freezing, storage, and transport of bioprocess fluids.

An image of a 2D IRIS single-use bag on a transparent background.

Key features

ULDPE material

Made from ultra-low-density polyethylene (ULDPE).

Designed for freezing

Supports storage and handling at temperatures down to -85°C

Available sizes

Available in volumes ranging from 20 mL to 10 L

Custom assemblies available

Tubing and connectors tailored to your process.

RoSS® shell compatible

Designed for use with the protective RoSS® shell

An image presenting three IRIS single-use bags manufactured by Single Use Support on a white background.

Storage and freezing with IRIS single-use bags

Safe storage and packaging are the factors that matter in liquid handling of drug substances. Our 2D single-use bags protect your high-value liquids. Product loss will be reduced towards 0%.

In the bioprocess containers the fluids are safe for freezing, transport and storage. Its PE film with ultra-low extractables & leachable profile is tested according to BPOG protocol.

Partially opened RoSS Shell containing a single-use bag.

Compatible with our IRIS single-use assemblies and RoSS® shell

All single-use bags are fully compatible with our single-use assemblies and protective shells RoSS® and RoSS.KSET. This allows for a fast and safe handling of your frozen liquids to the usual standards from a single source.

Our customers trust in us:

Downloads

Preview of datasheet for IRIS single-use bags by Single Use Support

Datasheet

IRIS Single-Use Bag - Datasheet

IRIS Single-Use Bag - Datasheet
 
Preview of an guide about IRIS single-use bags

Guide

Redefining safety in cold chain management with IRIS single-use bags - Guide

Redefining safety in cold chain management with IRIS single-use bags - Guide
 

Send a request

  • Protecting single-use bags to foster their progress

    Twenty years ago there was only steel. Biopharmaceutical manufacturing has been conducted by fixed stainless-steel installations for a long time. Pharmaceutical products were produced in rigid, inflexible vessels and pipings by cell culturing and/or fermentation, purification, filtering, filling and freezing. Only until single-use systems, such as single-use bags, aseptic fluid management tubings made of plastic, have proven to provide manufacturers with way more advantages for bioprocessing.They are more flexible, scalable, faster and cost effective. And yet there is hesitation. How can single-use technologies continue to thrive? What are the advantages of single-use systems Single-use solutions outperform in multiple areas: Universal applicability: Be it large scale manufacturing of vaccines, antibody-drug conjugates or emerging regenerative medicine, such as cell and gene therapy, single-use bags have solutions for every pharmaceutical manufacturing facility and every batch size. Diverse drug products and areas of applications benefit from single-use technologies. Process Efficiency: Single-use systems facilitate cost-competitive production processes in the biopharma industry by massive reduction of ressources for cleaning. These are for example costs for cleaning media, time consuming cleaning cycles, operator time and analytics. Also there is reduced risk of cross-contamination given. Having end-to-end solutions in place for drug substance handling that are compatible throughout different bioprocessing steps, such as liquid transfer, freezing & thawing and transportation, prove to have even higher efficiencies. Scale-up process: Breaking up conventional batch sizes shifting to small volumes for the clinical phase and large volumes in commercial productions, single-use bags allow companies to work more flexibly. Especially for innovative approaches of regenerative and individualized medicine and tissue engineering, single-use solutions are the logic process solution: It is necessary to fill, freeze and ship medication within a short period of time. Single-use equipment offers a multipurpose production due to enhanced throughput and changeover times. Also, scalable manufacturing productions with modular setups have made single-use systems recognized among manufacturers. [[1]] Sustainability: Single-use technologies are more sustainable than stainless-steel equipment on a holistic view. It is not only plastic to be recycled: Stainless-steel reactors and pipings are less sustainable since enormous amounts of water, energy and chemicals are required to ensure sterility. [[2]]   More advantages of single-use technologies   What are concerns caused by single-use systems to get full acceptance? In short: There is still potential product loss with unprotected single-use bags and there are still human errors dampening the euphoria of single-use systems. Single-use bags containing highly valuable drugs consist of multi-layer plastics which are vulnerable even at ambient temperature. They become glass-like when frozen and without protection are prone to breakages when handled incorrectly. Or sometimes even when handling correctly. RoSS (abbreviated for “robust storage and shipping”) is a protective shell for all 2D single-use bags. Independent from any single-use bag manufacturer or from any size, RoSS shell protects the bag from external forces during freezing, handling storage and shipment, but also from the inside: A soft 3D foam – as counterpart complementing the protective robust stainless-steel – absorbs the products’ natural expansion during freezing, provides full immobilization and hence guarantees avoidance of product loss. For smaller single-use bags the CAR T therapy single-use bag protection system RoSS.KSET is the ideal solution.  Its protective measures help to reduce human errors by mishandling single-use containers. The single-use bags are tamper-evidently sealed as closed system which prevents susceptibility to misuse. "We have achieved a 0% failure rate out of several batches after implementing RoSS shells" Principal Engineer, Multinational Biotechnology Company The RoSS® Shell has been invented by Single Use Support. Since then it has been tested in real-world scenarios by operators and experts in biopharmaceutical manufacturing. The big interest in such advanced innovations reflected the desire to avoid product loss by breakages. Read more: How to avoid single-use bag leakages in bioprocessing Proven and tested protection One of Single Use Support's numerous customers, an innovative global biopharma company, which has evolved as partner for further development of different products started to use RoSS shells almost 3 years ago. They have now reported “0% failure rate out of several batches” in 2020. This real-world evidence has strengthened the company's plans to rely on RoSS for another product launch in 2021. [[4]] The concept of RoSS platform has been proven trustworthy and reliably over the last years and adds a new perspective for companies which are still suffering from product loss caused by inadequate protection of single-use bags to regain trust in single-use systems.   More about RoSS® shell   Shaping Biopharma future trends The rising trust in RoSS® ability to enhance security standards mirrors the willingness to further establish single-use systems. It supports common goals to increase patient safety but also corporate goals to gain efficiency, safety and flexibility by implementation of smart end-to-end single-use solutions in biopharmaceutical processes. RoSS is a composition of both, robust stainless-steel and novel soft 3D foam. The latter metaphorically absorbs the remaining weaknesses of single-use bags – being the temporary highlight of the journey from a stainless-steel prone industry to a more and more single-use defining Biopharma industry. References: Langer, E., Rader, R.: Single-use technologies in biopharmaceutical manufacturing: A 10-year review of trends and the future, May 2014. Engineering in Life Sciences 14(3). DOI:10.1002/elsc.201300090 Whitford W., Petrich M.: Concerning Single-Use Systems and the Environment. 2018. Available at: https://www.bioprocessintl.com/single-use/ebook-sustainability-concerning-single-use-systems-and-the-environment Single Use Support. 2021: data on file. Exenberger C.: Case Study: Reducing product loss | Cost-efficiency, Published 2022

    READ MORE
  • Small volumes of ATMPs: Safe handling of single-use bags

    In recent years cell and gene therapies (CGT) have proven to be promising approaches to personalized medicine. Patients needing a cell and gene therapy as an advanced therapy medicinal product (ATMP) rely on their treatment being ready as soon as possible. For example, there are CAR T-cell therapies that have been approved for for very aggressive and hard-to-treat types of cancer. Moreover, CGTs yield a small volume of individualized product for each single patient. Loss of the shipment or damage to the transported goods have serious consequences for patients. Not only a safe transport, but also speed, accuracy and process flexibility play an important role in manufacturing and patient safety. Therefore, reliable, safe, and scalable solutions are needed. RoSS.KSET satisfies all those requirements. It is an integrated solution to protect and safely transport single-use bags for small volumes at low-temperature refrigeration. The secondary packaging also enables advanced fluid management and cold chain logistics by accessing modular aliquoting of small volumes into single-use containers and plate-based freezing for the best freezing performance.   More about RoSS KSET Single-use bag protection for ATMP During autologous cell therapies, each patient receives an individually manufactured product. Therefore, the drug substance is of unusually high value. Having a safe and standardized logistics process in place is essential for success. But also allogeneic cell therapies or viral vector production for gene therapies require a safe handling of small volumes. In this case even in different scales. In most cases, the volume of ATMP remains small. But either bag sizes or bag quantities can have an influence on manufacturing facilities.  RoSS.KSET is a solution to safely protect small volume single use bags of all types used in cell and gene therapies. It is designed to be used effortlessly by medical and biotechnological personnel: robust and closed construction, extra space for safe storage of satellite samples and vials.  Read more: How to avoid single-use bag leakages in bioprocessing Meeting high standards in cell and gene therapy Meeting the high standards in cell and gene therapy requires a huge effort in process and logistics optimization and standardizing. With highly personalized drug substances, e.g. CAR T-cells, strict requirements for the associated logistics and supply-chains have to be met. These parts of the CGT approach are essential to treat patients effectively and economically. Here, loss of drug substance is a major issue. Beyond implementing cGMP production into manufacturing facilities, automated solutions help fulfil 21 CFR Part 11 requirements. Reported audit trails and monitoring support the way to a more efficient manufacturing process of advanced therapies. Small scale solutions It all starts small. Therefore small scale solutions are required in various areas of pharma applications. Here is an except of where advanced solutions for small volumes are required Clinical studies from Phase I to Phase III Clinical trials Cell Banking  Autologous and allogeneic cell therapies Gene Therapies, including viral vector production Non-viral vector production, such as LNPs. Plasmid DNA It all involves the processing of small volumes of very highly valuable substances. It is essential to minimize any risk of failure, be it from inconsistencies and deviations while handling or damage of single use bags during the transport. To make ATMPs manufacturing work on a world-wide scale, innovative automated solutions to all these issues are needed. CGT bag protection system - read more   Secure protection of small volume bags The handling of highly valuable small volume single-use bags is challenging. At the cold temperatures needed to keep the drug substance from disintegrating, single-use bags become prone to breakages from impacts or vibrations during transportation. Even a tiny leak has serious consequences for the seriously ill prospective recipient of the CAR T-cell therapy. But also overfilling through manual filling can be a reason for leakages in single-use bags. Single Use Support’s RoSS.KSET was specifically designed to secure single use bags while being in the supply-chain. Their 3D foam lining offers protection against shocks and vibrations, and the robust construction offers a safe shell against impacts. The materials were chosen for their thermal conductance to ensure optimal behaviour during freezing and thawing. The compact design allows for efficient storage in cryoconditions. Fast and flexible transportation of small volume bags Cell and gene therapies require the handling of miniscule amounts of liquids, sometimes less than 5 mL. Standardization and automation of such processes are needed to reduce error rates and contamination risks. Single Use Support solved these challenges with a series of platform systems: RoSS.FILL is an automated aseptic filling platform with unprecedented filling accuracy. Its version for small volumes can fill single-use bags and medical devices with less than 5mL and unbeaten precision. It allows the automated processing of liquids with high flexibility. RoSS.pFTU and RoSS.LN2F are freezing and thawing platforms that are scalable and compatible with single use bags of all sizes and customized types. Both enable controlled freezing liquids in single-use bags.  Together with the protective shell RoSS.KSET, Single Use Support's filling and freezing platform solutions are an ideal part of the logistics side of personalized medicine. More about RoSS-pFTU platforms How Single Use Support's RoSS KSET helps to improve cell and gene therapies Cell and Gene therapies, such as CAR T-cell therapy, have proven their potential to become standard treatments to hard-to-treat diseases. Among the obstacles to their commercialization are the handling and logistics of small volumes of highly valuable and irrecoverable individualized drug substances. Single Use Support has developed end-to-end solution in transporting small but valuable therapies safely. As response to various day-to-day challenges of manufacturers, the platforms RoSS.FILL and RoSS.pFTU enable a safe and monitored aliquoting, freezing and thawing of small volumes into single use bags. The complementary shell RoSS.KSET protects the products from damage during storage and transportation. Single Use Support strives to further improve the ATMP manufacturing and make advanced therapies an affordable treatment option for patients all over the world. Learn more about RoSS.KSET

    Read more
  • Cold Chain Logistics in the pharmaceutical industry with single-use bags

    When it comes to the manufacturing and development of biopharmaceutics, single-use bioprocess container exhibit a vast number of advantages for cold chain logistics: Handling is easy, costs – both for acquisition, storage and transport – are low, and single-use bags are easy to store, yet they offer a high degree of reliability. This is not to say that there aren’t several phases during the cold chain logistics process that require closer inspection, as medical substances in various developmental stages are shipped around the globe. Some simple hacks can contribute to a safe journey to warrant the single-use bag’s intact arrival at its final destination and keep its precious contents protected from biocontamination and other damages. Pharmaceutical cold chain management – learn more Protecting Single-Use Bags The Right Way Temperatures of -80 °C (-62 °F) can cause single-use bags to rupture and materials to break, which can lead to an excessive waste of materials and resources, especially when it comes to high-quality substances. This is why it is imperative to protect the single-use bag during its controlled freezing – and afterwards – from the outside. For this reason, Single Use Support has developed a compact shell for the single-use freezing process. It ideally protects the single-use bag during storage, shipping and the bag freezing process. The shell is made of high-quality stainless steel that offers protection against external impact, while on the inside the bag is bedded in specially developed soft 3D foam. Each shell is tamper-proof so the bag contained in the RoSS® Shell cannot be accessed during the entire controlled freezing and logistics process. The RoSS® Shells are compatible with single-use bags of all established brands and manufacturers. High-quality freezing for advanced cold chain logistics Most manufacturers use traditional freezers to freeze their valuable biopharmaceutical substances. However, the most logical solution is not always necessarily the best one. The slow freezing process of traditional freezers impacts the quality of the medical substance. It leads to the formation of large crystals that can cause friction and will increase cryoconcentration. As a result, up to 20% of proteins can get destroyed. This can be countered with fast freezing. So-called plate freezer allows for a shock-like freezing effect that will maximize the quality of frozen biopharmaceutical substances.Plate freezing leads to a speedy and at the same time controlled freezing of the valuable liquid solution contained in the single-use bag. During freezing, the bags are protected by stainless-steel RoSS single-use shell, with the stainless steel offering the best possible temperature transfer from freezer to bag to liquid. The following curve illustrates the freezing speed during single-use freezing: [[download-1]] Special shipping containers maintain the cooling chain during cold chain logistics As already mentioned, drug substance logistics is characteristic for covering enormous distances during development and production of biopharmaceuticals. In order to maintain the cooling chain during the entire frozen bag shipment and storage, specialized shipping containers are required for a reliable pharmaceutical cold chain management. That is why we have developed cold chain shipping boxes and ultra cold storage containers with minimum space requirements to keep the RoSS Shells and their contents cool after the bag freezing process. The containers can carry up to 20 RoSS Shells and are, like the shells themselves, made from robust stainless steel. The cooling system inside the isolated containers is based on dry ice or so-called “Phase-Change Materials” (PCM). The containers are equipped with GPS chips so they can be tracked and localized throughout their journey. At the same time those chips allow for a constant monitoring of the temperature inside the containers to guarantee for a reliable and safe frozen bag shipment. IRIS Single-use bioprocess container  

    READ MORE

FAQ about single-use bags

What sizes of single-use bags are available?

+

IRIS Single-use bioprocess containers from Single Use Support are available from 20mL to 10L.

Standard BPC sizes are  20ml, 50ml, 100ml, 250ml, 500ml, 1L, 2L, 5L and 10L.

What validation guidelines are in place at Single Use Support bioprocess bags?

+

All single-use assemblies are sterile for cGMP production and are delivered within sterile packaging. They are compliant with FDA, ISO and other regulatory standards for the bioproduction and biotech industries, in line with what is necessary for you to prevent cross-contamination of your reagents.

For detailed information regarding steriliziation guidelines, Pharmacopoeia compliance and biocompatibility, please refer to our datasheet.